It is a trading private limited company based in Noida, Uttar Pradesh, India, established in 2011.
2011 | Noida, Uttar Pradesh, India | ActiveGlanza Biotech Private Limited, a active private limited company, was established on 10 September 2011 in Noida, Uttar Pradesh, India. Engaging in retail trading within the trade sector, it holds CIN: U74120UP2011PTC046547. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Priti Singh Rathor (Director), Sukriti Singh (Director), Vineet Kumar Singh (Director). Past directors included Kamlesh Singh, Ram Singh, Anita Singh. Its latest AGM occurred on 15 September 2019, with the balance sheet filed on 31 March 2019. It is based at T-34 Sec 11, Noida, Uttar Pradesh, 201301.
U74120UP2011PTC046547
046547
10 September 2011
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Glanza Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priti Singh Rathor | Director | 21 Dec 2016 | Current |
| Sukriti Singh | Director | 25 Jun 2013 | Current |
| Vineet Kumar Singh | Director | 25 Jun 2013 | Current |
| Anita Singh | Director | 10 Sep 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Jun 2013 | Past |
| Pramod Abcsdd | Director | 12 Jul 2013 | Past |
| Pramod Abcsdd | Director | 25 Jun 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glanza Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Glanza Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Glanza Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Glanza Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glanza Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Glanza Biotech Private Limited last Annual general meeting of members was held on 15 Sep 2019 as per latest MCA records. was documented.
The activity Glanza Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Kanpur. was completed.
Progress on Priti Singh Rathor was appointed as a Director was appointed as a Director on 21 Dec 2016 & has been associated with this company since 8 years 11 months . was documented.
The activity Sukriti Singh was appointed as a Director was appointed as a Director on 25 Jun 2013 & has been associated with this company since 12 years 5 months . was completed.
Vineet Kumar Singh was appointed as a Director was appointed as a Director on 25 Jun 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.
The activity Anita Singh was appointed as a Director was appointed as a Director on 10 Sep 2011 & has been associated with this company since 14 years 3 months . was completed.
The CIN of Glanza Biotech Private Limited is U74120UP2011PTC046547.
Glanza Biotech Private Limited is headquartered at T-34 Sec 11, Noida, Uttar Pradesh, 201301.
Glanza Biotech Private Limited was incorporated on 10 September 2011.
The current directors of Glanza Biotech Private Limited are
The primary industry of Glanza Biotech Private Limited is Trade.
Glanza Biotech Private Limited is unlisted.
The authorized capital of Glanza Biotech Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Glanza Biotech Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX